Register entry

Sichuan Qingmu Pharmaceutical Co., Ltd.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
7
Live patents
0
Countries
1
Base
China
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Sichuan Qingmu Pharmaceutical Co., Ltd.No.55, South Shunjiang Avenue, East Economic Development Zone, Dongpo District, Meishan, Sichuan 620036, China (CHN)Active ingredient (API) manufacture3014747858544412225
Catalogue

Drug listings by form and route

7

7 active NDC listings: 7 bulk ingredient. By marketing category: BULK INGREDIENT 7.

Dosage formNDCs
powder7
RouteNDCs
Labeller name on the listingNDCs
sichuan qingmu pharmaceutical co., ltd.7
Catalogue

Marketed products

7
BrandGeneric nameForm / routeNDC
-METHYLENE BLUEpowder82712-1005BULK INGREDIENT
-NICARDIPINE HYDROCHLORIDEpowder82712-1004BULK INGREDIENT
-Nalmefenepowder82712-1002BULK INGREDIENT
-Nilotinib Hydrochloride Monohydratepowder82712-1007BULK INGREDIENT
-Silodosinpowder82712-1006BULK INGREDIENT
-dabigatran etexilate mesylatepowder82712-1003BULK INGREDIENT
-ticagrelorpowder82712-1001BULK INGREDIENT
Neighbours

Registered in the same town

1
Compare

Comparable companies in China

Enquiry

Common questions

Is Sichuan Qingmu Pharmaceutical Co., Ltd. FDA approved?
Sichuan Qingmu Pharmaceutical Co., Ltd. holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Sichuan Qingmu Pharmaceutical Co., Ltd.'s drugs manufactured?
The FDA register lists Meishan. Registered operations: active ingredient (API) manufacture.
What drugs does Sichuan Qingmu Pharmaceutical Co., Ltd. make?
7 products are listed under Sichuan Qingmu Pharmaceutical Co., Ltd. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.